Abstract Coronavirus disease 2019 (COVID-19) was initially described as a viral infection of the respiratory tract. It is now known, however, that many other biological systems are affected, including the ...
Fiocruz will be testing BCG vaccine for the prevention of Covid-19 in Brazil
Existing studies shows that the BCG vaccine is efficient against other viral respiratory infectionsLearn more
Fiocruz PrInt: Selection of a PhD with Experience Abroad
LAST WEEK TO REGISTER (OCT 7)Learn more
Brazilian drug against schistosomiasis is approved by the FDA
For the first time, the USA Food and Drugs Administration has granted the status of orphan drug to a drug developed entirely in BrazilLearn more
Study suggests Covid-19 may cause brain damage
The research has observed that the SARS-CoV-2 can infect neural cells and create brain damageLearn more
Research evaluates public health response to Covid-19 in five countries
Researchers will compare data obtained in Brazil, Canada, China, France, and Mali, to gather the lessons learned from their responses to the pandemicLearn more
Portable device developed by Fiocruz may popularize molecular tests for COVID-19
The OmniLAMP makes it possible to run tests with safety levels similar to those of the PCR, but in a shorter time and at a lower cost.Learn more
Since 2015 Brazil has experienced the social repercussions of the Zika virus epidemic, thus raising a debate about: difficulties of diagnosis; healthcare access for children with Zika Congenital Syndrome (ZCS); ...
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The impacts of the disease may be beyond the respiratory system, also affecting mental health. ...
Epidemics occur within the existing ecosystem of socioeconomic determinants of health, including class, gender, race, income, employment and individuals’ physical environment. The Zika virus epidemic (2014–2017) demonstrated disproportionate effects of ...
Abstract Data is becoming ever more critical and valuable for both scientists and health authorities searching for answers to the COVID-19 crisis. Due to difficulties in diagnosing this infection in ...
The 2015 to 2017 outbreak of Zika generated global attention on the risk of a spectrum of neurological disorders posed to women and their unborn children—including, but not limited to, ...
Abstract Background Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination. ...
On March 11th, 2020, the World Health Organization (WHO) declared COVID-19 (the disease caused by the novel coronavirus SARS-CoV-2) a pandemic. As of this article's writing, more than 1.3 million ...
The emergence of Zika virus in 2015 challenged conventional ideas of mosquito-borne diseases, tested the resilience of health systems and embedded itself within local sociocultural worlds, with major implications for ...
The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary ...
03/09/2020 Lucas Rocha (IOC/Fiocruz) Several patients infected with the new coronavirus (SARS-CoV-2) show an exacerbated inflammatory response caused by an exagerated activity of the patient’s immune system, in the attempt to protect the body from the pathogen. This activity is ... Read more
25/08/2020 Icict/Fiocruz The new coronavirus pandemic has been posing unheard-of challenges to health information systems. Covid-19 data in Brazil, both at a state and municipal level, are crucial for the decision making on public policies and emergency measures to contain ... Read more
11/09/2020 Fiocruz Bahia A research has analyzed the performance of chimeric antigens for the diagnosis of chronic Chagas disease using rapid tests. The study led by researcher Fred Luciano Neves Santos, of Fiocruz Bahia, used serum samples from different geographical ... Read more
Saiba mais sobre a parceria Fiocruz+Universidade de Oxford para a produção de uma vacina contra a COVID-19
Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more
27/07/2020 Icict/Fiocruz Going back to school may represent an extra risk for more than 9.3 million Brazilians (4.4% of the overall population) who are elderly or adults (18 years and up) with chronic health conditions and at risk for Covid-19 ... Read more
Understanding the gendered dimensions of - COVID-19 - #InFocus
Watch the webinar in English
12/06/2020 Fiocruz The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be ... Read more
02/06/2020 Maíra Menezes (IOC/Fiocruz) Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2. The methodology ... Read more
Fiocruz researcher Gustavo Matta says "COVID deaths are not numbers"
WATCH (In portuguese)
Available in English and Portuguese
The course presents general concepts of yellow fever, aimed at health professionals who work in primary healthcare. At the end of this course, you will be able to:
- recognize areas at risk of disease transmission;
- identify urban and sylvatic cycles;
- review surveillance procedures;
- define the types of yellow fever cases in different epidemiological settings;
- review general measures to control yellow fever and preventive measures in addition to the vaccine